Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Sanofi Pasteur Receives Seed Virus to Produce New Influenza A(H1N1) Vaccine

By Pharmaceutical Processing | May 27, 2009

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group has received the new influenza A(H1N1) seedvirus, enabling the company tobegin the production process for an A(H1N1) vaccine. The emergence of a new influenza A(H1N1) virus strain recently led theWorld Health Organization (WHO) to declare a Level 5 pandemic alert, followinghuman-to-human spread of the virus into at least two countries in one WHOregion. “As a company committed to protecting human health, Sanofi Pasteur looksforward to quickly understanding how this virus performs in a vaccinemanufacturing environment and developing a working seed that will enablelarge-scale production,” said Wayne Pisano, President and CEO of SanofiPasteur. “This is an important step for engaging Sanofi Pasteur’s resourcesand expertise to support public health authorities and the directives theyprovide us.” Receipt of the seed virus means that Sanofi Pasteur will begin thedevelopment process, called “passaging,” that will yield a “working seed.”Passaging is the process for acclimating virus to grow in a productionenvironment at optimum yield. The passaging process is expected to takeapproximately two weeks. Following quality controls, Sanofi Pasteur will beprepared to begin industrial production as soon as directed by public healthagencies. Sanofi Pasteur operates influenza vaccine production facilities inSwiftwater, Pa. and Val de Reuil, France.

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE